The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Acid-Suppressive Medication Use and the Risk for Hospital-Acquired Pneumonia
Abstract
CONTEXT: The use of acid-suppressive medication has been steadily increasing, particularly in the inpatient setting, despite lack of an accepted indication in the majority of these patients. OBJECTIVE: To examine the association between acid-suppressive medication and hospital-acquired pneumonia. DESIGN, SETTING, AND PATIENTS: Prospective pharmacoepidemiologic cohort study. All patients who were admitted to a large, urban, academic medical center in Boston, Massachusetts, from January 2004 through December 2007; at least 18 years of age; and hospitalized for 3 or more days were eligible for inclusion. Admissions with time spent in the intensive care unit were excluded. Acid-suppressive medication use was defined as any order for a proton-pump inhibitor or histamine(2) receptor antagonist. Traditional and propensity-matched multivariable logistic regression were used to control for confounders. MAIN OUTCOME MEASURE: Incidence of hospital-acquired pneumonia, defined via codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), in patients exposed and unexposed to acid-suppressive medication. RESULTS: The final cohort comprised 63 878 admissions. Acid-suppressive medication was ordered in 52% of admissions and hospital-acquired pneumonia occurred in 2219 admissions (3.5%). The unadjusted incidence of hospital-acquired pneumonia was higher in the group exposed to acid-suppressive medication than in the unexposed group (4.9% vs 2.0%; odds ratio [OR], 2.6; 95% confidence interval [CI], 2.3-2.8). Using multivariable logistic regression, the adjusted OR of hospital-acquired pneumonia in the group exposed to acid-suppressive medication was 1.3 (95% CI, 1.1-1.4). The matched propensity-score analyses yielded identical results. The association was significant for proton-pump inhibitors (OR, 1.3; 95% CI, 1.1-1.4) but not for histamine(2) receptor antagonists (OR, 1.2; 95% CI, 0.98-1.4). CONCLUSIONS: In this large, hospital-based pharmacoepidemiologic cohort, acid-suppressive medication use was associated with 30% increased odds of hospital-acquired pneumonia. In subset analyses, statistically significant risk was demonstrated only for proton-pump inhibitor use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proton-pump inhibitors decrease elimination of gastric microbiota38 and increase immigration of bacteria into the lungs, which increases the risk of pneumonia.”
From The microbiome and critical illness (2016) · cites this paper as [148]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Comorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Adherence to a Mediterranean diet and survival in a Greek population
Trichopoulou, A., Costacou, T., Bamia, C., & Trichopoulos, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025039 · Cited by 4,397
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Fletcher, G. F., Balady, G. J., Amsterdam, E. A., Chaitman, B., Eckel, R., Fleg, J., Froelicher, V. F., Leon, A. S., Piña, I. L., Rodney, R., et al. (2001) · Circulation · doi:10.1161/hc3901.095960 · Cited by 1,923
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Dansinger, M. L., Gleason, J. A., Griffith, J. L., Selker, H. P., & Schaefer, E. J. (2005) · JAMA · doi:10.1001/jama.293.1.43 · Cited by 1,726
Effects of the amount and intensity of exercise on plasma lipoproteins
Kraus, W. E., Houmard, J. A., Duscha, B. D., Knetzger, K. J., Wharton, M. B., McCartney, J. S., Bales, C. W., Henes, S., Samsa, G. P., Otvos, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020194 · Cited by 1,554
Hesse, B. W., Nelson, D. E., Kreps, G. L., Croyle, R. T., Arora, N. K., Rimer, B. K., & Viswanath, K. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2618 · Cited by 1,523
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Keller, S., Bann, C. M., Dodd, S. L., Schein, J., Mendoza, T. R., & Cleeland, C. S. (2004) · The Clinical Journal of Pain · doi:10.1097/00002508-200409000-00005 · Cited by 1,233
Bruckert, E., Hayem, G., Dejager, S., Yau, C., & Bégaud, B. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5686-z · Cited by 1,226
Dial, S. (2005) · JAMA · doi:10.1001/jama.294.23.2989 · Cited by 954
Epidemiology and Outcomes of Health-care–Associated Pneumonia
Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948
Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs
Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 879
Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study
Trichopoulou, A., Orfanos, P., Norat, T., Bueno-de-Mesquita, B. H., Ocké, M. C., Peeters, P. H. M., van der Schouw, Y. T., Boeing, H., Hoffmann, K., Boffetta, P., et al. (2005) · BMJ · doi:10.1136/bmj.38415.644155.8f · Cited by 789
Driks, M. R., Craven, D. E., Celli, B. R., Manning, M., Burke, R. A., Garvin, G. M., Kunches, L. M., Farber, H. W., Wedel, S. K., & McCabe, W. R. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172204 · Cited by 754
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Lee, J. H., O’Keefe, J. H., Bell, D. S. H., Hensrud, D. D., & Holick, M. F. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.050 · Cited by 744
Reducing bias in a propensity score matched-pair sample using greedy matching techniques
Parsons, L. (2001) · Medical Entomology and Zoology · Cited by 733
Singh, R. B., Dubnov, G., Niaz, M. A., Ghosh, S., Singh, R., Rastogi, S. S., Manor, O., Pella, D., & Berry, E. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11472-3 · Cited by 663 · cited 4×
“Age, median (range), y 59 (18-106) 60 (18-107) .”
BackgroundInfluentialStress Ulcer Prophylaxis in Critically III Patients
Cook, D. J. (1996) · JAMA · doi:10.1001/jama.1996.03530280060038 · Cited by 599
Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577
The Role of Coenzyme Q10 in Statin-Associated Myopathy
Marcoff, L., & Thompson, P. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.049 · Cited by 537
Coverage by the news media of the benefits and risks of medications
Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J., Mah, C., & Soumerai, S. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422206 · Cited by 500
Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials
Kashani, A., Phillips, C. O., Foody, J. M., Wang, Y., Mangalmurti, S., Ko, D. T., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.106.624890 · Cited by 474
DUMOULIN, G. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90974-6 · Cited by 468
Priority Areas for National Action
Institute of Medicine (2003) · National Academies Press eBooks · doi:10.17226/10593 · Cited by 434
ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis
(1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.4.347 · Cited by 419
Use of Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia
Gülmez, S. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.950 · Cited by 342
Prod’hom, G., Leuenberger, P., Koerfer, J., Blum, A., Chiolero, R., Schaller, M.-D., Perret, C., Spinnler, O., Blondel, J., Siegrist, H. H., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-8-199404150-00005 · Cited by 306
Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia
Sarkar, M., Hennessy, S., & Yang, Y. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00005 · Cited by 301
Ridker, P. M., & Torres, J. (2006) · JAMA · doi:10.1001/jama.295.19.2270 · Cited by 300
Venditti, M., Falcone, M., Corrao, S., Licata, G., Serra, P., & the Study Group of the Italian Society of Internal Medicine* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00005 · Cited by 292
Outcomes in 45 Patients With Statin-Associated Myopathy
Hansen, K. E., Hildebrand, J. P., Ferguson, E. E., & Stein, J. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2671 · Cited by 280
Haas, J. S., Phillips, K. A., Gerstenberger, E. P., & Seger, A. C. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-11-200506070-00006 · Cited by 271
Statin Safety: An Overview and Assessment of the Data—2005
Bays, H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.006 · Cited by 264
Aseeri, M. A., Schroeder, T., Kramer, J., & Zackula, R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01975.x · Cited by 236
Impugning the Integrity of Medical Science
DeAngelis, C. D., & Fontanarosa, P. (2008) · JAMA · doi:10.1001/jama.299.15.1833 · Cited by 230
Overuse of acid-suppressive therapy in hospitalized patients1
Nardino, R. J., Vender, R. J., & Herbert, P. N. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03259.x · Cited by 225
Zedtwitz‐Liebenstein, K., Wenisch, C., Patruta, S., Parschalk, B., Daxböck, F., & Graninger, W. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205000-00026 · Cited by 207
Woloshin, S., & Schwartz, L. M. (2002) · JAMA · doi:10.1001/jama.287.21.2856 · Cited by 194
Heidelbaugh, J. J., & Inadomi, J. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00839.x · Cited by 182
Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorová, I., Svoboda, P., Scheer, P., Doubek, J., Rehorkova, D., Bosakova, H., & Ochmann, J. (2004) · PubMed · Cited by 180
Donowitz, L. G., Page, M. C., Mileur, B. L., & Guenthner, S. H. (1986) · Infection Control · doi:10.1017/s0195941700063748 · Cited by 177
Schwitzer, G. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050095 · Cited by 174
Toward “Pain-Free” Statin Prescribing: Clinical Algorithm for Diagnosis and Management of Myalgia
Jacobson, T. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.6.687 · Cited by 170
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
Cassels, A., Hughes, M. A., Cole, C., Mintzes, B. J., Lexchin, J., & McCormack, J. P. (2003) · Europe PMC (PubMed Central) · Cited by 164
DeAngelis, C. D. (2001) · JAMA · doi:10.1001/jama.286.1.89 · Cited by 162
Lowe, D. O., Mamdani, M. M., Kopp, A., Low, D. E., & Juurlink, D. N. (2006) · Clinical Infectious Diseases · doi:10.1086/508453 · Cited by 155
Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia
Lin, C., Li, T., & Lai, M.-M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02012 · Cited by 150
Acid Suppressive Therapy Use on an Inpatient Internal Medicine Service
Pham, C. Q. D., Regal, R. E., Bostwick, T. R., & Knauf, K. S. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g703 · Cited by 149
Integrating Complementary Medicine Into Cardiovascular Medicine
Vogel, J. H. K., Bolling, S. F., Costello, R. B., Guarneri, E. M., Krucoff, M. W., Longhurst, J. C., Olshansky, B., Pelletier, K. R., Tracy, C. M., Vogel, R. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.031 · Cited by 139
Heber, D., Lembertas, A. V., Lu, Q., Bowerman, S., & Go, V. L. W. (2001) · The Journal of Alternative and Complementary Medicine · doi:10.1089/107555301750164181 · Cited by 137
Parente, F., Cucino, C., Gallus, S., Bargiggia, S., Greco, S., Pastore, L., & Porro, G. B. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01600.x · Cited by 130
Backes, J. M., Venero, C. V., Gibson, C., Ruisinger, J. F., Howard, P. A., Thompson, P. D., & Moriarty, P. M. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1k604 · Cited by 127
Apte, N. M., Karnad, D. R., Tp, M., Tilve, G. H., MORYE, S., & Gg, B. (1992) · Critical Care Medicine · doi:10.1097/00003246-199205000-00008 · Cited by 123
Stress ulcer prophylaxis in hospitalized patients not in intensive care units
Arthur, R. R., & May, D. B. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060393 · Cited by 121
Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient
Prasad, G. V. R., Wong, T., Meliton, G., & Bhaloo, S. (2002) · Transplantation · doi:10.1097/00007890-200210270-00028 · Cited by 119
Effects of gastric alkalization on bacterial colonization in critically ill patients
Garvey, B., McCAMBLEY, J. A., & Tuxen, D. V. (1989) · Critical Care Medicine · doi:10.1097/00003246-198903000-00002 · Cited by 117
Ancker, J. S., & Flanagin, A. (2007) · Science and Engineering Ethics · doi:10.1007/s11948-007-9011-z · Cited by 112
Mott, D. A., & Cline, R. R. (2002) · PubMed · doi:10.1097/01.mlr.0000020926.85284.8e · Cited by 109
Bradford, R. H., Shear, C. L., Chremos, A. N., Dujovne, C. A., Franklin, F. A., Grillo, R. B., Higgins, J., Langendörfer, A., Nash, D. T., Pool, J. L., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90307-7 · Cited by 109
Stein, E. A., Ballantyne, C. M., Windler, E., Sirnes, P. A., Sussekov, A., Yigit, Z., Seper, C., & Gimpelewicz, C. R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.09.099 · Cited by 102
Simvastatin vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial
Becker, D. J., Gordon, R. Y., Morris, P. B., Yorko, J., Gordon, Y. J., Li, M., & Iqbal, N. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.7.758 · Cited by 83
Hartmann, M., Theiss, U., Huber, R., Lühmann, R., Bliesath, H., Wurst, W., & Lücker, P. W. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.0953-0673.1996.00359.x · Cited by 82
What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice
Steinman, M. A., Chren, M., & Landefeld, C. S. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0074-3 · Cited by 80
Gazi, I. F., Daskalopoulou, S. S., Nair, D. R., & Mikhailidis, D. P. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226267 · Cited by 79
Efficacy of Rosuvastatin (5 mg and 10 mg) Twice a Week in Patients Intolerant to Daily Statins
Gadarla, M., Kearns, A. K., & Thompson, P. D. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.061 · Cited by 79
Glueck, C. J., Aregawi, D., Agloria, M., Khalil, Q., Winiarska, M., Munjal, J., Gogineni, S., & Wang, P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.06.004 · Cited by 73
Qadeer, M. A., Richter, J. E., & Brotman, D. J. (2006) · Journal of Hospital Medicine · doi:10.1002/jhm.10 · Cited by 70
Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients
Huang, C.-F., Li, T.-C., Lin, C., Liu, C.-S., Shih, H.-C., & Lai, M.-M. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32801da137 · Cited by 66
The effect of omeprazole on human natural killer cell activity
Aybay, C., İmir, T., & Okur, H. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)00301-3 · Cited by 66
Influence of the News Media on Diagnostic Testing in the Emergency Department
Sharma, V., Dowd, M. D., Swanson, D. S., Slaughter, A. J., & Simon, S. D. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.3.257 · Cited by 61
Backes, J. M., Moriarty, P. M., Ruisinger, J. F., & Gibson, C. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.059 · Cited by 57
Chinese Red Rice-induced Myopathy
Smith, D. J., & Olive, K. E. (2003) · Southern Medical Journal · doi:10.1097/01.smj.0000100117.79718.dc · Cited by 54
Lapi, F., Gallo, E. R., Bernasconi, S., Vietri, M., Menniti‐Ippolito, F., Raschetti, R., Gori, L., Firenzuoli, F., Mugelli, A., & Vannacci, A. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03224.x · Cited by 53
Full Disclosure and the Funding of Biomedical Research
Schwartz, R. S., Curfman, G., Morrissey, S., & Drazen, J. M. (2008) · New England Journal of Medicine · doi:10.1056/nejme0802618 · Cited by 51
The Commercialisation of Medical and Scientific Reporting
Caulfield, T. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010038 · Cited by 49
The Effects of Cimetidine, Ranitidine, and Famotidine on Human Neutrophil Functions
Mikawa, K., Akamatsu, H., Nishina, K., Shiga, M., Nobuhiro Maekawa, A., Obara, H., & Niwa, Y. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199907000-00040 · Cited by 49
Decreasing LDL Cholesterol and Medication Cost With Every‐Other‐Day Statin Therapy
Juszczyk, M. A., Seip, R. L., & Thompson, P. D. (2005) · Preventive Cardiology · doi:10.1111/j.0197-3118.2005.04404.x · Cited by 47
Scagliarini, R., Magnani, E., Praticò, A., Bocchini, R., Sambo, P., & Pazzi, P. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-3052-4 · Cited by 47
Expanding Statin Use to Help More At-Risk Patients Is Causing Financial Heartburn
Mitka, M. (2003) · JAMA · doi:10.1001/jama.290.17.2243 · Cited by 45
Effect of Lansoprazole on Human Leukocyte Function
Capodicasa, E., Bellis, F. D., & Pelli, M. A. (1999) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979909052768 · Cited by 44
Li, M., Chapman, S. F., Agho, K., & Eastman, C. J. (2007) · Health Education Research · doi:10.1093/her/cym028 · Cited by 42
Activity Inhibition of Cytolytic Lymphocytes by Omeprazole
Scaringi, L., Cornacchione, P., Fettucciari, K., Rosati, E., Rossi, R., Marconi, P., & Capodicasa, E. (1996) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1996.d01-300.x · Cited by 41
Stress‐ulcer prophylaxis for general medical patients: A review of the evidence
Janicki, T. J., & Stewart, S. (2007) · Journal of Hospital Medicine · doi:10.1002/jhm.177 · Cited by 38
Corbett, S. M., Rebuck, J. A., Osler, T. M., Ahern, J. W., Healey, M. A., & Rogers, F. B. (2004) · Current Surgery · doi:10.1016/j.cursur.2004.03.014 · Cited by 37
Schwab, M. G., Oetzel, C., Mörike, K., Jägle, C., Gleiter, C. H., & Eichelbaum, M. F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.9.1065 · Cited by 30
Vercelli, L., Mongini, T., Olivero, N., Rodolico, C., Musumeci, O., & Palmucci, L. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00668_7.x · Cited by 20
How do you treat patients with myalgia who take statins?
Siddiqi, S., & Thompson, P. D. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0002-1 · Cited by 20
The Complex Process of Naming Drugs
Gundersen, L. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00042 · Cited by 16
Esophageal retention of capsules.
Parker, W. A. (1983) · PubMed · Cited by 6
XmasTM (brand substitution not permitted)
Bromley, J., & Buckley, N. A. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00767.x · Cited by 5
Flagged first, then by citations
Cited by
Sorted by citations
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations
Denny, J. C., Ritchie, M. D., Basford, M. A., Pulley, J. M., Bastarache, L., Brown-Gentry, K., Wang, D., Masys, D. R., Roden, D. M., & Crawford, D. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq126 · Cited by 1,219
Medical Complications After Stroke: A Multicenter Study
Langhorne, P., Stott, D. J., Robertson, L., MacDonald, J., Jones, L., McAlpine, C., Dick, F., Taylor, G. S., & Murray, G. (2000) · Stroke · doi:10.1161/01.str.31.6.1223 · Cited by 1,196
Medical complications after stroke
Kumar, S., Selim, M. H., & Caplan, L. R. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70266-2 · Cited by 637
Moayyedi, P., Eikelboom, J. W., Bosch, J., Connolly, S. J., Dyal, L., Shestakovska, O., Leong, D. P., Anand, S. S., Störk, S., Branch, K. R., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.056 · Cited by 511
The microbiome and critical illness
Dickson, R. P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00427-0 · Cited by 460
Metadata
- Authors
- Herzig, S. J.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Herzig, Shoshana J.
- ORCID
- Herzig, Shoshana J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-05-27
- Volume
- 301
- Issue
- 20
- Pages
- 2120
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2139301698
- Cited by
- 486
- References
- 99
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 21 · 2023: 17 · 2022: 14 · 2021: 24 · 2020: 23 · 2019: 29 · 2018: 26 · 2017: 35 · 2016: 23 · 2015: 31 · 2014: 36 · 2013: 45 · 2012: 38
- FWCI
- 33.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (T32-HP11001)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- acid-suppressive medications, proton pump inhibitors, H2 receptor antagonists, nosocomial pneumonia, hospitalized patients, inpatient drug use, propensity score matching, pharmacoepidemiology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cross Infection, Drug Utilization, Female, Histamine H2 Antagonists, Hospitalization, Humans, Male, Middle Aged, Pneumonia, Prospective Studies, Risk, Reproducibility of Results, Comorbidity, Logistic Models, Pharmacoepidemiology, International Classification of Diseases, Proton Pump Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review